FAQ

SB 277011

Known as: SB 277011-A, SB-277011, SB-277011-A 
 

Topic mentions per year

Topic mentions per year

2000-2018
02420002018

Related topics

Related topics

2 relations

Broader (2)

NitrilesTetrahydroisoquinolines

Related mentions per year

Related mentions per year

1944-2018
19401960198020002020
SB 277011
Nitriles
Tetrahydroisoquinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat.
INTRODUCTION Dopamine (DA) plays a key role in different aspects of the male sexual response, including sexual motivation and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2007
2007
Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain.
SB-277011-A is a dopamine D(3) receptor antagonist that exhibits over 100-fold selectivity over dopamine D(2) receptors and a… (More)
Is this relevant?
2005
2005
The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats.
The mesolimbic dopamine (DA) system plays an important role in mediating addiction to alcohol and other drugs of abuse. Recent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain.
Dopamine (DA) receptors are a major target for drugs employed in the treatment of neuropsychiatric disorders such as… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A
Conditioned stimuli (CS) previously paired with drugs of abuse can elicit cravings in humans, relapse to drug use, and can also… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.
dopamine D3 receptor is preferentially localized to the mesocorticolimbic dopaminergic system and has been hypothesized to play a… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2001
Review
2001
SB-277011 GlaxoSmithKline.
It is presumed that GlaxoSmithKline has taken over from SmithKline Beecham in investigating the highly selective dopamine D3… (More)
Is this relevant?
2001
2001
Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
1. In vitro studies with the selective dopamine D3 receptor antagonist SB-277011 were conducted in liver microsomes and… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
SB-277011-A (trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolininecarboxamide), is a brain… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2000
2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with…
A selective dopamine D(3) receptor antagonist offers the potential for an effective antipsychotic therapy, free of the serious… (More)
Is this relevant?